Marshall Woodworth

Mr. Woodworth has over 25 years of experience in finance with over 20 years in the life sciences and related sectors. He has experience in private and public company financial management and has worked closely with healthcare investors and analysts.

Prior to joining Vyluma, Mr. Woodworth held the position of Chief Financial Officer at Nevakar. Before that, he was Chief Financial Officer at Braeburn Pharmaceuticals, Inc., Aerocrine AB and Chief Financial Officer/Treasury and Assistant Secretary at Furiex Pharmaceuticals, Inc. He has also held positions at Eli Lilly and Company, Dow Chemical Company, Monsanto Company, and Milliken & Company.

Mr. Woodworth holds a BS degree from the University of Maryland and an MBA from Indiana University Bloomington.